|
Volumn 23, Issue 21, 2013, Pages 5860-5864
|
Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib
|
Author keywords
COX 2; Endocannabinoids; Lumiracoxib; Prostaglandins; Substrate selective inhibition
|
Indexed keywords
2 ARACHIDONOYLGLYCEROL;
ANANDAMIDE;
ANILINE;
ARACHIDONIC ACID;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
DES FLUOROLUMIRACOXIB;
DICLOFENAC;
ENDOCANNABINOID;
ETHANOLAMINE DERIVATIVE;
FLURBIPROFEN;
GLYCEROL DERIVATIVE;
INDOMETACIN;
LUMIRACOXIB;
METHYL GROUP;
PHENYLACETIC ACID;
PROSTAGLANDIN H2;
UNCLASSIFIED DRUG;
ARTICLE;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG STRUCTURE;
ENZYME INHIBITION;
HYDROGEN BOND;
IC 50;
OXYGENATION;
COX-2;
ENDOCANNABINOIDS;
LUMIRACOXIB;
PROSTAGLANDINS;
SUBSTRATE-SELECTIVE INHIBITION;
ANIMALS;
BINDING SITES;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
DICLOFENAC;
ENDOCANNABINOIDS;
MICE;
MOLECULAR DOCKING SIMULATION;
|
EID: 84885161313
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2013.08.097 Document Type: Article |
Times cited : (14)
|
References (22)
|